{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:08:53Z","timestamp":1787166533275,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001849","name":"Defence Research and Development Organisation","doi-asserted-by":"publisher","award":["O\/o DG (TM)81\/48222\/LSRB-311\/BTB\/2017"],"award-info":[{"award-number":["O\/o DG (TM)81\/48222\/LSRB-311\/BTB\/2017"]}],"id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001849","name":"Defence Research and Development Organisation","doi-asserted-by":"publisher","award":["O\/o DG (TM)81\/48222\/LSRB-311\/BTB\/2017"],"award-info":[{"award-number":["O\/o DG (TM)81\/48222\/LSRB-311\/BTB\/2017"]}],"id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001849","name":"Defence Research and Development Organisation","doi-asserted-by":"publisher","award":["O\/o DG (TM)81\/48222\/LSRB-311\/BTB\/2017"],"award-info":[{"award-number":["O\/o DG (TM)81\/48222\/LSRB-311\/BTB\/2017"]}],"id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12602-023-10176-1","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T03:02:22Z","timestamp":1698807742000},"page":"843-856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["In Vivo Acute Toxicity and Therapeutic Potential of a Synthetic Peptide, DP1 in a Staphylococcus aureus Infected Murine Wound Excision Model"],"prefix":"10.1007","volume":"17","author":[{"given":"Panchali","family":"Barman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakshu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhi","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Maan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Rishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avneet","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"10176_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/antibiotics9020056","volume":"9","author":"R Smith","year":"2020","unstructured":"Smith R, Russo J, Fiegel J et al (2020) Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails. Antibiotics 9:56","journal-title":"Antibiotics"},{"key":"10176_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10096-018-3393-5","volume":"38","author":"A Punjataewakupt","year":"2019","unstructured":"Punjataewakupt A, Napavichayanun S, Aramwit P (2019) The downside of antimicrobial agents for wound healing. Eur J Clin Microbiol Infect Dis 38:39\u201354","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10176_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/iwj.12049","volume":"12","author":"LJ Bessa","year":"2015","unstructured":"Bessa LJ, Fazii P, Di Giulio M et al (2015) Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection. Int Wound J 12:47\u201352","journal-title":"Int Wound J"},{"key":"10176_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00604-019-3989-1","volume":"187","author":"S Joshi","year":"2020","unstructured":"Joshi S, Sharma P, Siddiqui R et al (2020) A review on peptide functionalized graphene derivatives as nanotools for biosensing. Microchim Acta 187:1\u201315","journal-title":"Microchim Acta"},{"key":"10176_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s12602-019-09603-z","volume":"12","author":"J Stanbro","year":"2020","unstructured":"Stanbro J, Park JM, Bond M et al (2020) Topical delivery of lactobacillus culture supernatant increases survival and wound resolution in traumatic Acinetobacter baumannii infections. Probiotics and antimicrobial proteins 12:809\u2013818","journal-title":"Probiotics and antimicrobial proteins"},{"key":"10176_CR6","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2147\/IDR.S177247","volume":"11","author":"M Haque","year":"2018","unstructured":"Haque M, Sartelli M, McKimm J et al (2018) Health care-associated infections - an overview. Infect Drug Resist 11:2321\u20132333","journal-title":"Infect Drug Resist"},{"key":"10176_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"NA Turner","year":"2019","unstructured":"Turner NA, Sharma-Kuinkel BK, Maskarinec SA et al (2019) Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol 17:203\u2013218","journal-title":"Nat Rev Microbiol"},{"key":"10176_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SYC Tong","year":"2015","unstructured":"Tong SYC, Davis JS, Eichenberger E et al (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28:603\u2013661","journal-title":"Clin Microbiol Rev"},{"key":"10176_CR9","doi-asserted-by":"crossref","unstructured":"Hoffmann JP, Friedman JK, Wang Y et al (2020) In situ treatment with novel microbiocide inhibits methicillin resistant Staphylococcus aureus in a murine wound infection model. Front Microbiol 10","DOI":"10.3389\/fmicb.2019.03106"},{"key":"10176_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/1471-2334-14-328","volume":"14","author":"GCM Almeida","year":"2014","unstructured":"Almeida GCM, dos Santos MM, Lima NGM et al (2014) Prevalence and factors associated with wound colonization by Staphylococcus spp. and Staphylococcus aureus in hospitalized patients in inland northeastern Brazil: a cross-sectional study. BMC Infect Dis 14:328","journal-title":"BMC Infect Dis"},{"key":"10176_CR11","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00726-014-1804-1","volume":"46","author":"DJ Kim","year":"2014","unstructured":"Kim DJ, Lee YW, Park MK et al (2014) Efficacy of the designer antimicrobial peptide SHAP1 in wound healing and wound infection. Amino Acids 46:2333\u20132343","journal-title":"Amino Acids"},{"key":"10176_CR12","unstructured":"Prinzi A, Rohde R (2023) The role of bacterial biofilms in antimicrobial resistance. ASM Press"},{"key":"10176_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/viru.2.5.17724","volume":"2","author":"NK Archer","year":"2011","unstructured":"Archer NK, Mazaitis MJ, Costerton JW et al (2011) Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2:445\u2013459","journal-title":"Virulence"},{"key":"10176_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/03009734.2014.896437","volume":"119","author":"D Hughes","year":"2014","unstructured":"Hughes D, Karl\u00e9n A (2014) Discovery and preclinical development of new antibiotics. Ups J Med Sci 119:162\u2013169","journal-title":"Ups J Med Sci"},{"key":"10176_CR15","doi-asserted-by":"publisher","first-page":"112303","DOI":"10.1016\/j.colsurfb.2021.112303","volume":"211","author":"S Sharma","year":"2022","unstructured":"Sharma S, Barman P, Joshi S et al (2022) Multidrug resistance crisis during COVID-19 pandemic: role of anti-microbial peptides as next-generation therapeutics. Colloids Surf B 211:112303","journal-title":"Colloids Surf B"},{"key":"10176_CR16","doi-asserted-by":"crossref","unstructured":"Joshi S, Sharma S, Verma G et al (2022) Peptide functionalized nanomaterials as microbial sensors. Photophysics and Nanophysics in Therapeutics, Elsevier, 2022, pp 327\u201348","DOI":"10.1016\/B978-0-323-89839-3.00004-X"},{"key":"10176_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10989-023-10524-3","volume":"29","author":"P Barman","year":"2023","unstructured":"Barman P, Joshi S, Sharma S et al (2023) Strategic approaches to improvise peptide drugs as next generation therapeutics. Int J Pept Res Ther 29:61","journal-title":"Int J Pept Res Ther"},{"key":"10176_CR18","doi-asserted-by":"publisher","first-page":"fty007","DOI":"10.1093\/femspd\/fty007","volume":"76","author":"JJ Spencer","year":"2018","unstructured":"Spencer JJ, Pitts RE, Pearson RA et al (2018) The effects of antimicrobial peptides WAM-1 and LL-37 on multidrug-resistant Acinetobacter baumannii. Pathog Dis 76:fty007","journal-title":"Pathog Dis"},{"key":"10176_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fphar.2018.00281","volume":"9","author":"A Pfalzgraff","year":"2018","unstructured":"Pfalzgraff A, Brandenburg K, Weindl G (2018) Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol 9:281","journal-title":"Front Pharmacol"},{"key":"10176_CR20","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1038\/s41598-020-66230-3","volume":"10","author":"S Joshi","year":"2020","unstructured":"Joshi S, Siddiqui R, Sharma P et al (2020) Green synthesis of peptide functionalized reduced graphene oxide (rGO) nano bioconjugate with enhanced antibacterial activity. Sci Rep 10:9441","journal-title":"Sci Rep"},{"key":"10176_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12866-019-1657-6","volume":"19","author":"M Yang","year":"2019","unstructured":"Yang M, Zhang C, Hansen SA et al (2019) Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model. BMC Microbiol 19:293","journal-title":"BMC Microbiol"},{"key":"10176_CR22","doi-asserted-by":"crossref","unstructured":"Rima M, Rima M, Fajloun Z et al (2021) Antimicrobial peptides: a potent alternative to antibiotics. Antibiotics (Basel) 10","DOI":"10.3390\/antibiotics10091095"},{"key":"10176_CR23","doi-asserted-by":"crossref","unstructured":"Chen CH, Lu TK (2020) Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics (Basel) 9","DOI":"10.3390\/antibiotics9010024"},{"key":"10176_CR24","doi-asserted-by":"crossref","unstructured":"Moretta A, Scieuzo C, Petrone AM et al (2021) Antimicrobial peptides: a new hope in biomedical and pharmaceutical fields. Front Cell Infect Microbiol 453","DOI":"10.3389\/fcimb.2021.668632"},{"key":"10176_CR25","doi-asserted-by":"publisher","first-page":"12058","DOI":"10.1038\/s41598-022-16303-2","volume":"12","author":"P Sharma","year":"2022","unstructured":"Sharma P, Sharma S, Joshi S et al (2022) Design, characterization and structure-function analysis of novel antimicrobial peptides based on the N-terminal CATH-2 fragment. Sci Rep 12:12058","journal-title":"Sci Rep"},{"key":"10176_CR26","unstructured":"Mayank Maan HG, Joshi S, Sharma S, Rishi P, Saini A (2023) Synthetic peptide to combat Staphylococcus aureus-mediated infection: an in vitro and in vivo antimicrobial evaluation study"},{"key":"10176_CR27","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2174\/138161209788682325","volume":"15","author":"G Diamond","year":"2009","unstructured":"Diamond G, Beckloff N, Weinberg A et al (2009) The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15:2377\u20132392","journal-title":"Curr Pharm Des"},{"key":"10176_CR28","doi-asserted-by":"publisher","first-page":"170644","DOI":"10.1016\/j.peptides.2021.170644","volume":"146","author":"EM Martell","year":"2021","unstructured":"Martell EM, Gonz\u00e1lez-Garcia M, St\u00e4ndker L et al (2021) Host defense peptides as immunomodulators: the other side of the coin. Peptides 146:170644","journal-title":"Peptides"},{"key":"10176_CR29","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3389\/fmicb.2020.01902","volume":"11","author":"MA Alford","year":"2020","unstructured":"Alford MA, Baquir B, Santana FL et al (2020) Cathelicidin host defense peptides and inflammatory signaling: striking a balance. Front Microbiol 11:1902","journal-title":"Front Microbiol"},{"key":"10176_CR30","doi-asserted-by":"crossref","unstructured":"Wang G, Chen Z, Tian P et al (2022) Wound healing mechanism of antimicrobial peptide cathelicidin-DM. Front Bioeng Biotechnol 10","DOI":"10.3389\/fbioe.2022.977159"},{"key":"10176_CR31","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1128\/AAC.06304-11","volume":"56","author":"S-A Li","year":"2012","unstructured":"Li S-A, Lee W-H, Zhang Y (2012) Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models. Antimicrob Agents Chemother 56:3309\u20133317","journal-title":"Antimicrob Agents Chemother"},{"key":"10176_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jhin.2022.03.006","volume":"126","author":"T Locke","year":"2022","unstructured":"Locke T, Parsons H, Briffa N et al (2022) A bundle of infection control measures reduces postoperative sternal wound infection due to Staphylococcus aureus but not Gram-negative bacteria: a retrospective analysis of 6903 patient episodes. J Hosp Infect 126:21\u201328","journal-title":"J Hosp Infect"},{"key":"10176_CR33","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1097\/SLA.0000000000003053","volume":"271","author":"S Roy","year":"2020","unstructured":"Roy S, Santra S, Das A et al (2020) Staphylococcus aureus biofilm infection compromises wound healing by causing deficiencies in granulation tissue collagen. Ann Surg 271:1174\u20131185","journal-title":"Ann Surg"},{"key":"10176_CR34","unstructured":"NCCLS (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th edn. Approved standard M7-A6, National Committee for Clinical Laboratory Standards, Wayne"},{"key":"10176_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","volume":"48","author":"JM Andrews","year":"2001","unstructured":"Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48:5\u201316","journal-title":"J Antimicrob Chemother"},{"key":"10176_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.yrtph.2004.12.006","volume":"42","author":"E Schlede","year":"2005","unstructured":"Schlede E, Genschow E, Spielmann H et al (2005) Oral acute toxic class method: a successful alternative to the oral LD50 test. Regul Toxicol Pharmacol 42:15\u201323","journal-title":"Regul Toxicol Pharmacol"},{"key":"10176_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.biopha.2018.12.142","volume":"111","author":"N Tatiya-Aphiradee","year":"2019","unstructured":"Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K (2019) Anti-inflammatory effect of Garcinia mangostana Linn. pericarp extract in methicillin-resistant Staphylococcus aureus-induced superficial skin infection in mice. Biomed Pharmacother 111:705\u2013713","journal-title":"Biomed Pharmacother"},{"key":"10176_CR38","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3389\/fmicb.2020.01767","volume":"11","author":"L Shang","year":"2020","unstructured":"Shang L, Li J, Song C et al (2020) Hybrid antimicrobial peptide targeting Staphylococcus aureus and displaying anti-infective activity in a murine model. Front Microbiol 11:1767","journal-title":"Front Microbiol"},{"key":"10176_CR39","unstructured":"Stoeber B, Ranamukha S, St. Clair R (2018) Intradermal delivery \u2013 new technology brings simplicity & scalability to intradermal drug delivery. Drug Deliv Development"},{"key":"10176_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/B978-0-12-381365-7.00013-3","volume-title":"Nonhuman Primates in Biomedical Research (Second Edition)","author":"RF Wolf","year":"2012","unstructured":"Wolf RF, White GL (2012) Chapter 13 - Clinical techniques used for Nonhuman primates. In: Abee CR, Mansfield K, Tardif S et al (eds) Nonhuman Primates in Biomedical Research (Second Edition). Academic Press, Boston, pp 323\u2013337"},{"key":"10176_CR41","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12602-020-09713-z","volume":"13","author":"CF Moreira","year":"2021","unstructured":"Moreira CF, Cassini-Vieira P, Canesso MCC et al (2021) Lactobacillus rhamnosus CGMCC 1.3724 (LPR) improves skin wound healing and reduces scar formation in mice. Probiotics Antimicrob Proteins 13:709\u2013719","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10176_CR42","doi-asserted-by":"publisher","first-page":"10319","DOI":"10.1016\/j.biomaterials.2013.09.037","volume":"34","author":"H-N Huang","year":"2013","unstructured":"Huang H-N, Rajanbabu V, Pan C-Y et al (2013) Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries. Biomaterials 34:10319\u201310327","journal-title":"Biomaterials"},{"key":"10176_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0892-0362(99)00069-0","volume":"22","author":"AS Driver","year":"2000","unstructured":"Driver AS, Kodavanti PRS, Mundy WR (2000) Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol 22:175\u2013181","journal-title":"Neurotoxicol Teratol"},{"key":"10176_CR44","unstructured":"Luck H (1974) Methods in enzymatic analysis II (ed.) Bergmeyer.(publ.). Academic Press, New York"},{"key":"10176_CR45","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1016\/S0021-9258(18)97085-7","volume":"240","author":"V Massey","year":"1965","unstructured":"Massey V, Williams CH (1965) On the reaction mechanism of yeast glutathione reductase. J Biol Chem 240:4470\u20134480","journal-title":"J Biol Chem"},{"key":"10176_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1208\/s12249-022-02481-9","volume":"24","author":"ZHF Al-Saedi","year":"2022","unstructured":"Al-Saedi ZHF, Salih ZT, Ahmed KK et al (2022) Formulation and characterization of oleogel as a topical carrier of azithromycin. AAPS PharmSciTech 24:17","journal-title":"AAPS PharmSciTech"},{"key":"10176_CR47","doi-asserted-by":"publisher","first-page":"e0257190","DOI":"10.1371\/journal.pone.0257190","volume":"16","author":"S Hema-Ouangraoua","year":"2021","unstructured":"Hema-Ouangraoua S, Tranchot-Diallo J, Zongo I et al (2021) Impact of mass administration of azithromycin as a preventive treatment on the prevalence and resistance of nasopharyngeal carriage of Staphylococcus aureus. PLoS ONE 16:e0257190","journal-title":"PLoS ONE"},{"key":"10176_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0924-8579(95)00009-W","volume":"5","author":"IM Hoepelman","year":"1995","unstructured":"Hoepelman IM, Schneider MME (1995) Azithromycin: the first of the tissue-selective azalides. Int J Antimicrob Agents 5:145\u2013167","journal-title":"Int J Antimicrob Agents"},{"key":"10176_CR49","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/0002-9343(91)90395-E","volume":"91","author":"HC Neu","year":"1991","unstructured":"Neu HC (1991) Clinical microbiology of azithromycin. Am J Med 91:S12\u2013S18","journal-title":"Am J Med"},{"key":"10176_CR50","doi-asserted-by":"crossref","unstructured":"Castle SS (2007) Ampicillin. In: Enna SJ, Bylund DB (eds) xPharm: the comprehensive pharmacology reference, Elsevier, New York, pp 1\u20136","DOI":"10.1016\/B978-008055232-3.61227-9"},{"key":"10176_CR51","unstructured":"Peechakara BV, Gupta M (2022) Ampicillin\/sulbactam. In: StatPearls [Internet]. StatPearls publishing"},{"key":"10176_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12929-014-0090-2","volume":"21","author":"Y Teethaisong","year":"2014","unstructured":"Teethaisong Y, Autarkool N, Sirichaiwetchakoon K et al (2014) Synergistic activity and mechanism of action of Stephania suberosa Forman extract and ampicillin combination against ampicillin-resistant Staphylococcus aureus. J Biomed Sci 21:90","journal-title":"J Biomed Sci"},{"key":"10176_CR53","doi-asserted-by":"publisher","unstructured":"Watson A, Sauve K, Cassino C et al (2020) Exebacase demonstrates in vitro synergy with a broad range of antibiotics against both methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01885-19","DOI":"10.1128\/aac.01885-19"},{"key":"10176_CR54","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1093\/cid\/ciz004","volume":"68","author":"Y Golan","year":"2019","unstructured":"Golan Y (2019) Current treatment options for acute skin and skin-structure infections. Clin Infect Dis 68:S206\u2013S212","journal-title":"Clin Infect Dis"},{"key":"10176_CR55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fphar.2017.00553","volume":"8","author":"C-L Dong","year":"2017","unstructured":"Dong C-L, Li L-X, Cui Z-H et al (2017) Synergistic effect of pleuromutilins with other antimicrobial agents against Staphylococcus aureus in vitro and in an experimental Galleria mellonella model. Front Pharmacol 8:553","journal-title":"Front Pharmacol"},{"key":"10176_CR56","first-page":"204","volume":"4","author":"A Yameen","year":"2010","unstructured":"Yameen A, Nasim H, Akhtar N et al (2010) Antibiotic susceptibility profile of methicillin-resistant staphylococci isolated from nasal samples of hospitalized patients. Afr J Microbiol Res 4:204\u2013209","journal-title":"Afr J Microbiol Res"},{"key":"10176_CR57","first-page":"e6749","volume":"12","author":"VK Moses","year":"2020","unstructured":"Moses VK, Kandi V, Rao SKD (2020) Minimum inhibitory concentrations of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolated from various clinical specimens: a study from South India. Cureus 12:e6749","journal-title":"Cureus"},{"key":"10176_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-016-0791-7","volume":"16","author":"A Jo","year":"2016","unstructured":"Jo A, Ahn J (2016) Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin. BMC Microbiol 16:1\u201310","journal-title":"BMC Microbiol"},{"key":"10176_CR59","doi-asserted-by":"crossref","unstructured":"Ochoa R (2002) 14 - Pathology issues in the design of toxicology studies. In: Haschek WM, Rousseaux CG, Wallig MA (eds) Handbook of Toxicologic Pathology (Second Edition), Academic Press, San Diego, pp 307\u201326","DOI":"10.1016\/B978-012330215-1\/50015-6"},{"key":"10176_CR60","doi-asserted-by":"crossref","unstructured":"Brody T (2018) Chapter 6 - Animal studies. In: Brody T (ed) FDA\u2019s drug review process and the package label, Academic Press, pp 187\u2013254","DOI":"10.1016\/B978-0-12-814647-7.00006-3"},{"key":"10176_CR61","doi-asserted-by":"publisher","first-page":"101568","DOI":"10.1016\/j.mex.2021.101568","volume":"8","author":"E Agathokleous","year":"2021","unstructured":"Agathokleous E, Moore MN, Calabrese EJ (2021) Estimating the no-observed-adverse-effect-level (NOAEL) of hormetic dose-response relationships in meta-data evaluations. MethodsX 8:101568","journal-title":"MethodsX"},{"key":"10176_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1053\/nbin.2001.23176","volume":"1","author":"F Strodtbeck","year":"2001","unstructured":"Strodtbeck F (2001) Physiology of wound healing. Newborn Infant Nurs Rev 1:43\u201352","journal-title":"Newborn Infant Nurs Rev"},{"key":"10176_CR63","first-page":"409","volume":"28","author":"P Beldon","year":"2010","unstructured":"Beldon P (2010) Basic science of wound healing. Surg Infect (Larchmt) 28:409\u2013412","journal-title":"Surg Infect (Larchmt)"},{"key":"10176_CR64","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/molecules23092392","volume":"23","author":"I Negut","year":"2018","unstructured":"Negut I, Grumezescu V, Grumezescu AM (2018) Treatment strategies for infected wounds. Molecules (Basel, Switzerland) 23:2392","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10176_CR65","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1093\/cid\/civ528","volume":"61","author":"AF Cardona","year":"2015","unstructured":"Cardona AF, Wilson SE (2015) Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment. Clin Infect Dis 61:S69\u2013S78","journal-title":"Clin Infect Dis"},{"key":"10176_CR66","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1038\/s41598-021-86844-5","volume":"11","author":"C-J Jung","year":"2021","unstructured":"Jung C-J, Liao Y-D, Hsu C-C et al (2021) Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia. Sci Rep 11:7318","journal-title":"Sci Rep"},{"key":"10176_CR67","unstructured":"Dijksteel GS (2021) Potential novel antimicrobial therapies for burn wounds: peptides and cold plasma. NARCIS"},{"key":"10176_CR68","doi-asserted-by":"publisher","first-page":"e0216669-e","DOI":"10.1371\/journal.pone.0216669","volume":"14","author":"S-U Gorr","year":"2019","unstructured":"Gorr S-U, Flory CM, Schumacher RJ (2019) In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K. PLoS ONE 14:e0216669-e","journal-title":"PLoS ONE"},{"key":"10176_CR69","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s12010-016-2166-9","volume":"180","author":"Z Ni","year":"2016","unstructured":"Ni Z, Wang B, Ma X et al (2016) Toxicology assessment of a dual-function peptide 5rolGLP-HV in mice. Appl Biochem Biotechnol 180:1276\u20131285","journal-title":"Appl Biochem Biotechnol"},{"key":"10176_CR70","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jare.2019.06.003","volume":"20","author":"R Cebri\u00e1n","year":"2019","unstructured":"Cebri\u00e1n R, Rodr\u00edguez-Cabezas ME, Mart\u00edn-Escolano R et al (2019) Preclinical studies of toxicity and safety of the AS-48 bacteriocin. J Adv Res 20:129\u2013139","journal-title":"J Adv Res"},{"key":"10176_CR71","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fmicb.2020.00103","volume":"11","author":"B El Shazely","year":"2020","unstructured":"El Shazely B, Yu G, Johnston PR et al (2020) Resistance evolution against antimicrobial peptides in Staphylococcus aureus alters pharmacodynamics beyond the MIC. Front Microbiol 11:103","journal-title":"Front Microbiol"},{"key":"10176_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/OPTO.S189115","volume":"11","author":"RK Thomas","year":"2019","unstructured":"Thomas RK, Melton R, Asbell PA (2019) Antibiotic resistance among ocular pathogens: current trends from the ARMOR surveillance study (2009\u20132016). Clin Optom (Auckl) 11:15\u201326","journal-title":"Clin Optom (Auckl)"},{"key":"10176_CR73","doi-asserted-by":"crossref","unstructured":"Miklasi\u0144ska-Majdanik M (2021) Mechanisms of resistance to macrolide antibiotics among Staphylococcus aureus. Antibiotics (Basel) 10","DOI":"10.3390\/antibiotics10111406"},{"key":"10176_CR74","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1093\/jac\/dkz341","volume":"74","author":"A Bojang","year":"2019","unstructured":"Bojang A, Baines SL, Donovan L et al (2019) Genomic investigation of Staphylococcus aureus recovered from Gambian women and newborns following an oral dose of intra-partum azithromycin. J Antimicrob Chemother 74:3170\u20133178","journal-title":"J Antimicrob Chemother"},{"key":"10176_CR75","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s13104-017-2964-3","volume":"10","author":"TA Nigatu","year":"2017","unstructured":"Nigatu TA, Afework M, Urga K et al (2017) Toxicological investigation of acute and chronic treatment with Gnidia stenophylla Gilg root extract on some blood parameters and histopathology of spleen, liver and kidney in mice. BMC Res Notes 10:625","journal-title":"BMC Res Notes"},{"key":"10176_CR76","first-page":"29","volume":"77","author":"AA Adedapo","year":"2007","unstructured":"Adedapo AA, Abatan MO, Olorunsogo OO (2007) Effects of some plants of the spurge family on haematological and biochemical parameters in rats. Vet Arhiv 77:29\u201338","journal-title":"Vet Arhiv"},{"key":"10176_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0378-8741(03)00193-4","volume":"88","author":"JO Adebayo","year":"2003","unstructured":"Adebayo JO, Yakubu MT, Egwim EC et al (2003) Effect of ethanolic extract of Khaya senegalensis on some biochemical parameters of rat kidney. J Ethnopharmacol 88:69\u201372","journal-title":"J Ethnopharmacol"},{"key":"10176_CR78","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.pharmtox.48.113006.094615","volume":"48","author":"VS Vaidya","year":"2008","unstructured":"Vaidya VS, Ferguson MA, Bonventre JV (2008) Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48:463\u2013493","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10176_CR79","doi-asserted-by":"publisher","first-page":"e00370","DOI":"10.1128\/mSphere.00370-17","volume":"2","author":"VAF Schneider","year":"2017","unstructured":"Schneider VAF, Coorens M, Tjeerdsma-van Bokhoven JL et al (2017) Imaging the antistaphylococcal activity of CATH-2: mechanism of attack and regulation of inflammatory response. mSphere 2:e00370-e417","journal-title":"mSphere"},{"key":"10176_CR80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/exd.12929","volume":"25","author":"ML Mangoni","year":"2016","unstructured":"Mangoni ML, McDermott AM, Zasloff M (2016) Antimicrobial peptides and wound healing: biological and therapeutic considerations. Exp Dermatol 25:167\u2013173","journal-title":"Exp Dermatol"},{"key":"10176_CR81","doi-asserted-by":"publisher","first-page":"fty072","DOI":"10.1093\/femspd\/fty072","volume":"76","author":"P Rishi","year":"2018","unstructured":"Rishi P, Vashist T, Sharma A et al (2018) Efficacy of designer K11 antimicrobial peptide (a hybrid of melittin, cecropin A1 and magainin 2) against Acinetobacter baumannii-infected wounds. Pathog Dis 76:fty072","journal-title":"Pathog Dis"},{"key":"10176_CR82","doi-asserted-by":"publisher","first-page":"30657","DOI":"10.1021\/acsomega.2c02675","volume":"7","author":"S Polaka","year":"2022","unstructured":"Polaka S, Katare P, Pawar B et al (2022) Emerging ROS-modulating technologies for augmentation of the wound healing process. ACS Omega 7:30657\u201330672","journal-title":"ACS Omega"},{"key":"10176_CR83","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/iwj.12557","volume":"14","author":"C Dunnill","year":"2017","unstructured":"Dunnill C, Patton T, Brennan J et al (2017) Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process. Int Wound J 14:89\u201396","journal-title":"Int Wound J"},{"key":"10176_CR84","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/stresses2030019","volume":"2","author":"CMC Andr\u00e9s","year":"2022","unstructured":"Andr\u00e9s CMC, P\u00e9rez de la Lastra JM, Juan CA et al (2022) Chemistry of hydrogen peroxide formation and elimination in mammalian cells, and its role in various pathologies. Stresses 2:256\u2013274","journal-title":"Stresses"},{"key":"10176_CR85","doi-asserted-by":"crossref","unstructured":"Ransy C, Vaz C, Lomb\u00e8s A et al (2020) Use of H(2)O(2) to cause oxidative stress, the catalase issue. Int J Mol Sci 21","DOI":"10.3390\/ijms21239149"},{"key":"10176_CR86","doi-asserted-by":"publisher","first-page":"9613090","DOI":"10.1155\/2019\/9613090","volume":"2019","author":"A Nandi","year":"2019","unstructured":"Nandi A, Yan LJ, Jana CK et al (2019) Role of catalase in oxidative stress- and age-associated degenerative diseases. Oxid Med Cell Longev 2019:9613090","journal-title":"Oxid Med Cell Longev"},{"key":"10176_CR87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.abb.2012.04.014","volume":"525","author":"S Mishra","year":"2012","unstructured":"Mishra S, Imlay J (2012) Why do bacteria use so many enzymes to scavenge hydrogen peroxide? Arch Biochem Biophys 525:145\u2013160","journal-title":"Arch Biochem Biophys"},{"key":"10176_CR88","unstructured":"Agarwal P, Singh A, Gaurav K et al (2009) Evaluation of wound healing activity of extracts of plantain banana (Musa sapientum var. paradisiaca) in rats"},{"key":"10176_CR89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1365-2613.2000.00158.x","volume":"81","author":"AM Rasik","year":"2000","unstructured":"Rasik AM, Shukla A (2000) Antioxidant status in delayed healing type of wounds. Int J Exp Pathol 81:257\u2013263","journal-title":"Int J Exp Pathol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-023-10176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-023-10176-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-023-10176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:57:48Z","timestamp":1742583468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-023-10176-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10176"],"URL":"https:\/\/doi.org\/10.1007\/s12602-023-10176-1","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"10 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}